Fifth Lane Capital’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Fifth Lane Capital’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-50,100	Closed	-$481K	–	55
2024 Q4	$481K	Buy	+50,100	New	+$261K	1.41%	12

Other funds holding PSTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Fifth Lane Capital's PSTX Position: Q1 2025 in Review

Fifth Lane Capital sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 50,100 shares — an estimated $481K sold.

Fifth Lane Capital first reported a position in PSTX in Q4 2024 and held it in 1 quarter. The position peaked at $481K in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

Fifth Lane Capital reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Fifth Lane Capital sold 50,100 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $481K.
Fifth Lane Capital first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
Fifth Lane Capital's Poseida Therapeutics, Inc. Common Stock position peaked at $481K in Q4 2024.
1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Fifth Lane Capital's 13F filing for Q1 2025, filed 13 May 2025.